Wang et al. demonstrated that cell lines and tumor samples harboring a frameshift variant in the exon 10 of BRCA1 expressed a BRCA1 isoform that confers a partial resistance to chemotherapy and PARPis. This evidence concerns the gene BRCA1 and neoplasm.